These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

869 related items for PubMed ID: 20817518

  • 21. Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease.
    Muñoz-Ruiz P, Rubio L, García-Palomero E, Dorronsoro I, del Monte-Millán M, Valenzuela R, Usán P, de Austria C, Bartolini M, Andrisano V, Bidon-Chanal A, Orozco M, Luque FJ, Medina M, Martínez A.
    J Med Chem; 2005 Nov 17; 48(23):7223-33. PubMed ID: 16279781
    [Abstract] [Full Text] [Related]

  • 22. Synthesis and biological activity of derivatives of tetrahydroacridine as acetylcholinesterase inhibitors.
    Szymański P, Markowicz M, Mikiciuk-Olasik E.
    Bioorg Chem; 2011 Aug 17; 39(4):138-42. PubMed ID: 21621811
    [Abstract] [Full Text] [Related]

  • 23. Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties.
    Fernández-Bachiller MI, Pérez C, González-Muñoz GC, Conde S, López MG, Villarroya M, García AG, Rodríguez-Franco MI.
    J Med Chem; 2010 Jul 08; 53(13):4927-37. PubMed ID: 20545360
    [Abstract] [Full Text] [Related]

  • 24. Nontoxic and neuroprotective β-naphthotacrines for Alzheimer's disease.
    Esquivias-Pérez M, Maalej E, Romero A, Chabchoub F, Samadi A, Marco-Contelles J, Oset-Gasque MJ.
    Chem Res Toxicol; 2013 Jun 17; 26(6):986-92. PubMed ID: 23676090
    [Abstract] [Full Text] [Related]

  • 25. Synthesis and acetylcholinesterase/butyrylcholinesterase inhibition activity of new tacrine-like analogues.
    Marco JL, de los Ríos C, Carreiras MC, Baños JE, Badía A, Vivas NM.
    Bioorg Med Chem; 2001 Mar 17; 9(3):727-32. PubMed ID: 11310608
    [Abstract] [Full Text] [Related]

  • 26. Synthesis and in vitro evaluation of 7-methoxy-N-(pent-4-enyl)-1,2,3,4-tetrahydroacridin-9-amine-new tacrine derivate with cholinergic properties.
    Korabecny J, Musilek K, Zemek F, Horova A, Holas O, Nepovimova E, Opletalova V, Hroudova J, Fisar Z, Jung YS, Kuca K.
    Bioorg Med Chem Lett; 2011 Nov 01; 21(21):6563-6. PubMed ID: 21920739
    [Abstract] [Full Text] [Related]

  • 27. Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors.
    Hamulakova S, Janovec L, Hrabinova M, Spilovska K, Korabecny J, Kristian P, Kuca K, Imrich J.
    J Med Chem; 2014 Aug 28; 57(16):7073-84. PubMed ID: 25089370
    [Abstract] [Full Text] [Related]

  • 28. Novel tacrine-melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties.
    Rodríguez-Franco MI, Fernández-Bachiller MI, Pérez C, Hernández-Ledesma B, Bartolomé B.
    J Med Chem; 2006 Jan 26; 49(2):459-62. PubMed ID: 16420031
    [Abstract] [Full Text] [Related]

  • 29. Synthesis, kinetic studies and molecular modeling of novel tacrine dimers as cholinesterase inhibitors.
    de Aquino RA, Modolo LV, Alves RB, de Fátima Â.
    Org Biomol Chem; 2013 Dec 28; 11(48):8395-409. PubMed ID: 24186541
    [Abstract] [Full Text] [Related]

  • 30. Synthesis and Cholinesterase Inhibitory Activity of N-Phosphorylated/ N-Tiophosphorylated Tacrine.
    Przybyłowska M, Inkielewicz-Stepniak I, Kowalski S, Dzierzbicka K, Demkowicz S, Daśko M.
    Med Chem; 2020 Dec 28; 16(7):947-957. PubMed ID: 31309898
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Rational approach to discover multipotent anti-Alzheimer drugs.
    Rosini M, Andrisano V, Bartolini M, Bolognesi ML, Hrelia P, Minarini A, Tarozzi A, Melchiorre C.
    J Med Chem; 2005 Jan 27; 48(2):360-3. PubMed ID: 15658850
    [Abstract] [Full Text] [Related]

  • 33. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.
    Yu Q, Holloway HW, Utsuki T, Brossi A, Greig NH.
    J Med Chem; 1999 May 20; 42(10):1855-61. PubMed ID: 10346939
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Novel heterobivalent tacrine derivatives as cholinesterase inhibitors with notable selectivity toward butyrylcholinesterase.
    Elsinghorst PW, Tanarro CM, Gütschow M.
    J Med Chem; 2006 Dec 14; 49(25):7540-4. PubMed ID: 17149883
    [Abstract] [Full Text] [Related]

  • 37. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
    Sheng R, Lin X, Zhang J, Chol KS, Huang W, Yang B, He Q, Hu Y.
    Bioorg Med Chem; 2009 Sep 15; 17(18):6692-8. PubMed ID: 19692250
    [Abstract] [Full Text] [Related]

  • 38. Tacrine-flurbiprofen hybrids as multifunctional drug candidates for the treatment of Alzheimer's disease.
    Chen Y, Sun J, Peng S, Liao H, Zhang Y, Lehmann J.
    Arch Pharm (Weinheim); 2013 Dec 15; 346(12):865-71. PubMed ID: 24203864
    [Abstract] [Full Text] [Related]

  • 39. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease.
    Keri RS, Quintanova C, Marques SM, Esteves AR, Cardoso SM, Santos MA.
    Bioorg Med Chem; 2013 Aug 01; 21(15):4559-69. PubMed ID: 23768661
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.